{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:00Z","timestamp":1789643100533,"version":"4.0.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2025.06.034","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:08:35Z","timestamp":1750331315000},"page":"955-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Part II: Dermatologic manifestations associated with treatment of patients with kidney disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Amit","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"Cowper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry I.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Robinson-Bostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.06.034_bib1","series-title":"Chronic Kidney Disease in the United States Centers for Disease Control and Prevention","year":"2021"},{"key":"10.1016\/j.jaad.2025.06.034_bib2","series-title":"Chronic Kidney Disease in the United States","year":"2023"},{"key":"10.1016\/j.jaad.2025.06.034_bib3","series-title":"Chronic Kidney Disease: Common Serious, and Costly 2024","year":"2024"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.034_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ad.2015.05.007","article-title":"Skin manifestations of chronic kidney disease","volume":"106","author":"Robles-Mendez","year":"2015","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib5","article-title":"Dermatological manifestations in patients with chronic kidney disease: a review","volume":"16","author":"Arriaga Escamilla","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s11255-017-1514-1","article-title":"Calcifying panniculitis in peritoneal dialysis: no need to switch to hemodialysis","volume":"49","author":"Zomer","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib7","first-page":"156","article-title":"Calcifying panniculitis with renal failure: a new management approach","volume":"192","author":"Elamin","year":"1996","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.034_bib8","first-page":"1207","article-title":"Intravenous treatment of calcinosis cutis with sodium thiosulfate - a case series","volume":"22","author":"Bruns","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.034_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ad.2015.09.001","article-title":"Calcinosis cutis and calciphylaxis","volume":"106","author":"Jim\u00e9nez-Gallo","year":"2015","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2010.08.038","article-title":"Calcinosis cutis: part I. Diagnostic pathway","volume":"65","author":"Reiter","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2021.10.064","article-title":"Calciphylaxis: Part I. Diagnosis and pathology","volume":"86","author":"Rick","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamadermatol.2018.4937","article-title":"Demographics, comorbid conditions, and outcomes of patients with nonuremic calciphylaxis","volume":"155","author":"Altman","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"18","key":"10.1016\/j.jaad.2025.06.034_bib14","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib15","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MNH.0000000000000328","article-title":"Calciphylaxis","volume":"26","author":"Nigwekar","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.034_bib17","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1681\/ASN.2015091065","article-title":"A nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2025.06.034_bib18","doi-asserted-by":"crossref","first-page":"S724","DOI":"10.1007\/s11606-014-2910-1","article-title":"Quantifying a rare disease in administrative data: the example of calciphylaxis","volume":"29 Suppl 3","author":"Nigwekar","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jaad.2025.06.034_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-020-01722-y","article-title":"Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study","volume":"21","author":"Gaisne","year":"2020","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaad.2021.10.063","article-title":"Calciphylaxis: treatment and outlook-CME part II","volume":"86","author":"Rick","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2010.08.039","article-title":"Calcinosis cutis: part II. Treatment options","volume":"65","author":"Reiter","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib22","first-page":"395","article-title":"Update on calciphylaxis etiopathogenesis, diagnosis, and management","volume":"102","author":"Khanna","year":"2018","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cup.13364","article-title":"Factors associated with false-negative pathologic diagnosis of calciphylaxis","volume":"46","author":"Williams","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2025.06.034_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9526836","article-title":"A case of early calciphylaxis diagnosed by bone scan","volume":"2020","author":"Di","year":"2020","journal-title":"Case Rep Med"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2020.05.101","article-title":"The role of skin biopsy in diagnosis and management of calciphylaxis: a retrospective analysis","volume":"85","author":"Dobry","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.06.034_bib26","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s11255-017-1721-9","article-title":"Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy","volume":"49","author":"Santos","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MNH.0000000000000520","article-title":"Revisiting therapeutic options for calciphylaxis","volume":"28","author":"Seethapathy","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.10221014","article-title":"The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial","volume":"10","author":"Floege","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.034_bib29","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/bcp.13752","article-title":"First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification","volume":"84","author":"Perell\u00f3","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2023.07.1031","article-title":"A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis","volume":"90","author":"Biglione","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.ajkd.2022.06.011","article-title":"Calciphylaxis and kidney disease: a review","volume":"81","author":"Gallo Marin","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0006-291X(85)91948-5","article-title":"A new form of amyloid protein associated with chronic hemodialysis was identified as \u03b22-microglobulin","volume":"129","author":"Gejyo","year":"1985","journal-title":"Biochem biophysical Res Commun"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2133.2003.05466.x","article-title":"Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity?","volume":"149","author":"Shimizu","year":"2003","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.034_bib34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/art.1780280913","article-title":"Synovial amyloidosis in patients undergoing long-term hemodialysis","volume":"28","author":"Bardin","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2025.06.034_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/IJNRD.S84784","article-title":"Dialysis-related amyloidosis: challenges and solutions","volume":"9","author":"Scarpioni","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib36","doi-asserted-by":"crossref","first-page":"c173","DOI":"10.1159\/000199457","article-title":"A circulating beta 2-microglobulin intermediate in hemodialysis patients","volume":"111","author":"Uji","year":"2009","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00774-019-01028-6","article-title":"Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndrome","volume":"38","author":"Tagami","year":"2020","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib38","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/ki.1997.262","article-title":"Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study","volume":"51","author":"Jadoul","year":"1997","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib39","first-page":"495","article-title":"Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function","volume":"123","author":"McCarthy","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0272-6386(97)90281-X","article-title":"Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis","volume":"30","author":"Hartmann","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib41","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ki.1991.128","article-title":"Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis","volume":"39","author":"van Ypersele de Strihou","year":"1991","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2340\/00015555-0342","article-title":"Dialysis-related amyloidosis on the buttocks","volume":"88","author":"Takayama","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00256-020-03560-3","article-title":"Amyloidoma: a review and case report","volume":"50","author":"Desai","year":"2021","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13506120903090783","article-title":"Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis","volume":"16","author":"Montagna","year":"2009","journal-title":"Amyloid"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.034_bib45","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.34067\/KID.0004922020","article-title":"Beta-2 microglobulin amyloidosis: past, present, and future","volume":"1","author":"Portales-Castillo","year":"2020","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamadermatol.2014.5022","article-title":"Massive subcutaneous masses on the back related to \u03b22-microglobulin amyloidosis","volume":"151","author":"Gargallo","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000529091","article-title":"Nail amyloidoma: two case reports of a new entity","volume":"9","author":"Bonito","year":"2023","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib48","article-title":"Surgical treatment of ischial ulcers associated with deposition of \u03b22-microglobulin in two cases of dialysis-related amyloidosis","volume":"11","author":"Fujita","year":"2023","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib49","first-page":"73","article-title":"Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient","volume":"53","author":"Floege","year":"1989","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib50","first-page":"312","article-title":"Macroglossia and amyloidoma of the buttock: evidence of systemic involvement in dialysis amyloid","volume":"55","author":"Sethi","year":"1990","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.034_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jcp.46.8.771","article-title":"Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis","volume":"46","author":"Fern\u00e1ndez-Alonso","year":"1993","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib52","first-page":"651","article-title":"Bilateral beta 2-microglobulin amyloidomas of the buttocks in a long-term hemodialysis patient","volume":"118","author":"Tom","year":"1994","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2214\/AJR.05.0221","article-title":"Dialysis-related amyloidoma presenting as a bilateral gluteal mass","volume":"186","author":"Libicher","year":"2006","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib54","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2214\/AJR.04.1309","article-title":"Dialysis-related amyloidosis revisited","volume":"185","author":"Kiss","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.034_bib55","article-title":"Primary localised cutaneous amyloidosis\u2013a systematic review","volume":"60","author":"Kaltoft","year":"2013","journal-title":"Dan Med J"},{"key":"10.1016\/j.jaad.2025.06.034_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.carpath.2019.05.002","article-title":"The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis","volume":"42","author":"Morris","year":"2019","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.ajkd.2008.02.296","article-title":"Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial","volume":"52","author":"Pellicano","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.034_bib58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/000313481708301017","article-title":"Predictors of steal in hemodialysis access","volume":"83","author":"Korn","year":"2017","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejvs.2003.10.007","article-title":"Upper extremity ischemia and hemodialysis vascular access","volume":"27","author":"Tordoir","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.suc.2013.05.002","article-title":"Hemodialysis access","volume":"93","author":"Rose","year":"2013","journal-title":"Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/jsre.1997.5206","article-title":"Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure","volume":"74","author":"Morsy","year":"1998","journal-title":"J Surg Res"},{"key":"10.1016\/j.jaad.2025.06.034_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.avsg.2021.12.017","article-title":"Risk factors and management of hemodialysis associated distal ischemia","volume":"82","author":"Lee","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"15","key":"10.1016\/j.jaad.2025.06.034_bib63","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2024.0535","article-title":"Arteriovenous access for hemodialysis: a review","volume":"331","author":"Lok","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib64","first-page":"477","article-title":"Antebrachial cutaneous necrosis following reconstruction of an arteriovenous fistula in a hemodialysis patient","volume":"30","author":"Bordils Gil","year":"2010","journal-title":"Nefrolog\u00eda"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib65","first-page":"157","article-title":"The value of noninvasive testing before and after hemodialysis access in the prevention and management of complications","volume":"10","author":"Rutherford","year":"1997","journal-title":"Semin Vasc Surg"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib66","first-page":"9113","article-title":"Therapeutic management of a symptomatic Kaposi's sarcoma patient with renal failure undergoing haemodialysis: a case report","volume":"14","author":"Passarelli","year":"2022","journal-title":"Dermatol Rep"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/2229-5178.137791","article-title":"Acroangiodermatitis (Pseudo-Kaposi sarcoma)","volume":"5","author":"Singh","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","article-title":"Kaposi sarcoma","volume":"137","author":"Radu","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaad.2025.06.034_bib69","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2147\/CCID.S411081","article-title":"Pseudo-Kaposi's sarcoma: a rare case and review","volume":"16","author":"Li","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3, Supplement 1","key":"10.1016\/j.jaad.2025.06.034_bib70","doi-asserted-by":"crossref","first-page":"AB33","DOI":"10.1016\/j.jaad.2009.11.174","article-title":"A case of unusual idiopathic pseudo\u2013Kaposi sarcoma","volume":"62","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-4362.1994.tb04944.x","article-title":"Acroangiodermatitis: a study of ten cases","volume":"33","author":"Rao","year":"1994","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib72","article-title":"Human herpesvirus 8 (HHV-8) staining: a savior in early Kaposi sarcoma","volume":"15","author":"Siddiqui","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib73","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7241\/ourd.20183.19","article-title":"Pseudokaposi's sarcoma: a diagnostic dilemma","volume":"9","author":"Chatnallikar","year":"2018","journal-title":"Our Dermatol Online"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1346-8138.1997.tb02734.x","article-title":"Pseudo-Kaposi's sarcoma associated with acquired arteriovenous fistula","volume":"24","author":"Kim","year":"1997","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2340\/0001555575475478","article-title":"Acro-angiodermatitis: review of the literature and report of a case","volume":"75","author":"Rashkovsky","year":"1995","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/iwj.12074","article-title":"Stewart-Bluefarb syndrome: review of the literature and case report of chronic ulcer treatment with heparan sulphate (Cacipliq20\u00ae)","volume":"12","author":"Hayek","year":"2015","journal-title":"Int Wound J"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.034_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/0268355514548090","article-title":"Stewart-Bluefarb syndrome: report of five cases and a review of literature","volume":"30","author":"Parsi","year":"2015","journal-title":"Phlebology"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D332H5G5K2","article-title":"Acroangiodermatitis","volume":"13","author":"Heller","year":"2007","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5339\/qmj.2022.fqac.18","article-title":"Contact dermatitis in hemodialysis patients at Al Wakra hospital","volume":"2022","author":"Elmadhoun","year":"2022","journal-title":"Qatar Med J"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1398-9995.2008.01833.x","article-title":"Contact allergies in haemodialysis patients: a prospective study of 75 patients","volume":"64","author":"Gaudy-Marqueste","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib81","first-page":"20","article-title":"Epidemiologic study of contact dermatitis in hemodialysis patients","volume":"7","author":"Gonzalo","year":"1997","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/sdi.13197","article-title":"Hypersensitive reactions during hemodialysis treatment: what do we need to know?","volume":"37","author":"Afsar","year":"2024","journal-title":"Semin Dial"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib83","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ki.1996.441","article-title":"Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group","volume":"50","author":"Locatelli","year":"1996","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17219\/pim\/102974","article-title":"Dialysis membranes: a 2018 update","volume":"48","author":"Olczyk","year":"2018","journal-title":"Polim Med"},{"key":"10.1016\/j.jaad.2025.06.034_bib85","series-title":"Comprehensive Membrane Science and Engineering","first-page":"351","article-title":"2.13 - progress in the development of membranes for kidney-replacement therapy","author":"Zweigart","year":"2010"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib86","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1159\/000493662","article-title":"Incidence of hypersensitivity reactions during hemodialysis","volume":"43","author":"Esteras","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2215\/CJN.05260516","article-title":"Diagnosis, treatment, and prevention of hemodialysis emergencies","volume":"12","author":"Saha","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib88","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1111\/hdi.12801","article-title":"Dialysis-associated allergic reactions during continuous renal replacement therapy and hemodialysis: a case report","volume":"24","author":"Chen","year":"2020","journal-title":"Hemodial Int"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib89","first-page":"163","volume":"17","author":"Simon","year":"1996","journal-title":"Nephrologie"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.ajkd.2022.12.004","article-title":"Anaphylaxis from ethylene oxide-sterilized dialysis tubing and needles: a case report","volume":"82","author":"Crane","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib91","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/sdi.12449","article-title":"Anaphylactic shock at the beginning of hemodialysis","volume":"29","author":"Sayeed","year":"2016","journal-title":"Semin Dial"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.034_bib92","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/ndt\/12.7.1461","article-title":"Ethylene oxide allergy in dialysis patients","volume":"12","author":"Purello D'Ambrosio","year":"1997","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib93","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ki.1994.195","article-title":"Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes","volume":"45","author":"Verresen","year":"1994","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.034_bib94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2006.00158.x","article-title":"Dialyzer reuse\u2013part II: advantages and disadvantages","volume":"19","author":"Twardowski","year":"2006","journal-title":"Semin Dial"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib95","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","article-title":"Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran","volume":"61","author":"Michael","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.034_bib96","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0091-6749(86)90351-9","article-title":"Anaphylactic shock caused by formaldehyde in a patient undergoing long-term hemodialysis","volume":"77","author":"Maurice","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1525-1594.1999.06176.x","article-title":"Prevalence of latex sensitivity among patients with chronic renal failure: a new risk group?","volume":"23","author":"Kalpaklioglu","year":"1999","journal-title":"Artif Organs"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.034_bib98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00044011-200424070-00005","article-title":"Hypersensitivity to nadroparin calcium : case report and review of the literature","volume":"24","author":"Ebo","year":"2004","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib99","first-page":"698","article-title":"Hypersensitivity reactions to synthetic haemodialysis membranes \u2014 an emerging issue?","volume":"34","author":"Alvarez-de Lara","year":"2014","journal-title":"Nefrologia"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.15585\/mmwr.mm7206e1","article-title":"Vital signs: health disparities in hemodialysis-associated Staphylococcus aureus bloodstream infections - United States, 2017-2020","volume":"72","author":"Rha","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.034_bib101","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.11411116","article-title":"National Healthcare Safety Network (NHSN) dialysis event surveillance report for 2014","volume":"12","author":"Nguyen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2025.06.034_bib102","series-title":"US Renal Data System: USRDS 2022 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2022"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib103","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3947\/ic.2020.52.1.82","article-title":"Higher risk for all-cause mortality of Staphylococcus aureus bacteremia in patients with non-dialysis dependent chronic kidney disease","volume":"52","author":"Kim","year":"2020","journal-title":"Infect Chemother"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.034_bib104","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002480-200011000-00031","article-title":"Staphylococcus aureus infections in dialysis patients: focus on prevention","volume":"46","author":"Piraino","year":"2000","journal-title":"ASAIO J"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/cid\/civ901","article-title":"Clinical effectiveness of mupirocin for preventing Staphylococcus aureus infections in nonsurgical settings: a meta-analysis","volume":"62","author":"Nair","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.034_bib106","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.mri.2016.08.017","article-title":"Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience","volume":"34","author":"Kanal","year":"2016","journal-title":"Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib107","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jamainternmed.2019.5278","article-title":"Risk of gadolinium-based contrast agents in chronic kidney disease\u2014is zero good enough?","volume":"180","author":"Maripuri","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib108","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jmri.25625","article-title":"Gadolinium-based contrast agents: a comprehensive risk assessment","volume":"46","author":"Fraum","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jaad.2025.06.034_bib110","series-title":"Dermatological Manifestations of Kidney Disease","author":"Nunley","year":"2015"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib111","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.2019182916","article-title":"A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis","volume":"292","author":"Attari","year":"2019","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib112","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib113","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2502080498","article-title":"Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment\u2013report of 33 cases","volume":"250","author":"Perez-Rodriguez","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jaad.2025.06.034_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214927","article-title":"Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media","volume":"2016","author":"He","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"9234","key":"10.1016\/j.jaad.2025.06.034_bib115","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.034_bib116","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","article-title":"Nephrogenic fibrosing dermopathy with systemic involvement","volume":"139","author":"Ting","year":"2003","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.034_bib117","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.22925","article-title":"Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure","volume":"56","author":"Todd","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.034_bib118","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","article-title":"Gadolinium deposition in nephrogenic fibrosing dermopathy","volume":"56","author":"Boyd","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.034_bib119","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.0303-6987.2005.00365.x","article-title":"Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema","volume":"32","author":"Kucher","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.034_bib120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1525-139X.2007.00399.x","article-title":"NSF: what we know and what we need to know: nephrogenic systemic fibrosis: early recognition and treatment","volume":"21","author":"Knopp","year":"2008","journal-title":"Semin Dial"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.034_bib121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaad.2005.11.1091","article-title":"A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis","volume":"54","author":"Knobler","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222502359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222502359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:58:38Z","timestamp":1789642718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222502359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S019096222502359X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Part II: Dermatologic manifestations associated with treatment of patients with kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}